Literature DB >> 28111264

Cardiac stem cell aging and heart failure.

Daniela Cesselli1, Aneta Aleksova2, Elisa Mazzega1, Angela Caragnano1, Antonio Paolo Beltrami3.   

Abstract

A side effect of the medical improvements of the last centuries is the progressive aging of the world population, which is estimated to reach the impressive number of 2 billion people with more than 65 years by 2050. As a consequence, age-related diseases, such as heart failure, will affect more and more patients in the next years. To understand the biological bases of these diseases will be a crucial task in order to find better treatments, and possibly slow age-related morbidity and mortality. Cardiac stem cells have been at the center of a heated debate and their potential involvement in cardiac homeostasis has been questioned. In this review, we summarize evidence obtained by independent groups, on different animal models and humans, that strongly support the important role played by immature, cardiac resident cells in the cardioprotection against heart failure.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Cardiomyocyte turnover; Cardiospheres; Cell senescence; Heart failure; PDGFRα; Sca1; Stem cells; cKit

Mesh:

Year:  2017        PMID: 28111264     DOI: 10.1016/j.phrs.2017.01.013

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

Review 1.  Cardiac Cell Senescence and Redox Signaling.

Authors:  Daniela Cesselli; Aneta Aleksova; Sandro Sponga; Celeste Cervellin; Carla Di Loreto; Gianluca Tell; Antonio Paolo Beltrami
Journal:  Front Cardiovasc Med       Date:  2017-05-29

Review 2.  Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease.

Authors:  Eleonora Cianflone; Michele Torella; Flavia Biamonte; Antonella De Angelis; Konrad Urbanek; Francesco S Costanzo; Marcello Rota; Georgina M Ellison-Hughes; Daniele Torella
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

3.  Blood Serum Stimulates p38-Mediated Proliferation and Changes in Global Gene Expression of Adult Human Cardiac Stem Cells.

Authors:  Anna L Höving; Kazuko E Schmidt; Madlen Merten; Jassin Hamidi; Ann-Katrin Rott; Isabel Faust; Johannes F W Greiner; Jan Gummert; Barbara Kaltschmidt; Christian Kaltschmidt; Cornelius Knabbe
Journal:  Cells       Date:  2020-06-16       Impact factor: 6.600

4.  Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells.

Authors:  Ji Hye Park; Na Kyoung Lee; Hye Ji Lim; Seung Taek Ji; Yeon-Ju Kim; Woong Bi Jang; Da Yeon Kim; Songhwa Kang; Jisoo Yun; Jong Seong Ha; Hyungtae Kim; Dongjun Lee; Sang Hong Baek; Sang-Mo Kwon
Journal:  Exp Mol Med       Date:  2020-04-09       Impact factor: 8.718

Review 5.  The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.

Authors:  Cristina Carresi; Miriam Scicchitano; Federica Scarano; Roberta Macrì; Francesca Bosco; Saverio Nucera; Stefano Ruga; Maria Caterina Zito; Rocco Mollace; Lorenza Guarnieri; Anna Rita Coppoletta; Micaela Gliozzi; Vincenzo Musolino; Jessica Maiuolo; Ernesto Palma; Vincenzo Mollace
Journal:  Nutrients       Date:  2021-01-19       Impact factor: 5.717

6.  Estrogen is required for maintaining the quality of cardiac stem cells.

Authors:  Al Shaimaa Hasan; Lan Luo; Satoko Baba; Tao-Sheng Li
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.